Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype

JU Shuhui, LI Hengyu

PDF(3623 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(3623 KB)
World Clinical Drug ›› 2022, Vol. 43 ›› Issue (04) : 347-351. DOI: 10.13683/j.wph.2022.04.001
Recommendation

Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 43(04): 347-351 https://doi.org/10.13683/j.wph.2022.04.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3623 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉